Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 66 institutions that hold shares in the stock, with a total of 9.27 Million shares, which have been reported (via 13F filing form) to have a value of $10 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
3,310,517
shares
|
$3.58 Million
0.0% of portfolio
|
Q1 2024
Reduced 4.26%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
826,581
shares
|
$892,707
0.0% of portfolio
|
Q4 2023
Added 8.76%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
824,700
shares
|
$890,676
0.0% of portfolio
|
Q1 2024
Added 23.9%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
754,110
shares
|
$814,438
0.0% of portfolio
|
Q1 2024
Added 4.08%
|
|
Gsa Capital Partners LLP
London, X0 |
May 03, 2024 Q1 2024 |
493,571
shares
|
$533,056
0.05% of portfolio
|
Q1 2024
Reduced 9.31%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
458,145
shares
|
$494,796
0.0% of portfolio
|
Q1 2024
Reduced 7.3%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
330,047
shares
|
$356,450
0.0% of portfolio
|
Q1 2024
Added 9.04%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
271,795
shares
|
$293,538
0.0% of portfolio
|
Q4 2023
Added 3.71%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2024 Q1 2024 |
183,790
shares
|
$198,493
0.0% of portfolio
|
Q1 2024
Reduced 11.97%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
173,071
shares
|
$186,916
0.0% of portfolio
|
Q1 2024
Reduced 30.63%
|
|
Virtu Financial LLC
New York, NY |
May 20, 2024 Q1 2024 |
157,516
shares
|
$170,117
0.02% of portfolio
|
Q1 2024
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
153,561
shares
|
$165,845
0.0% of portfolio
|
Q3 2023
Added 19.58%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
114,560
shares
|
$123,724
0.0% of portfolio
|
Q1 2024
Reduced 43.6%
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
92,424
shares
|
$99,817
0.0% of portfolio
|
Q1 2024
Reduced 11.54%
|
|
Two Sigma Securities, LLC
New York, NY |
May 15, 2024 Q1 2024 |
85,313
shares
|
$92,138
0.0% of portfolio
|
Q1 2024
Added 91.83%
|
|
Barclays PLC
London, X0 |
May 15, 2024 Q1 2024 |
82,434
shares
|
$89,028
0.0% of portfolio
|
Q1 2024
Reduced 34.42%
|
|
Rhumbline Advisers
Boston, MA |
May 09, 2024 Q1 2024 |
76,455
shares
|
$82,571
0.0% of portfolio
|
Q1 2024
Added 3.76%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
76,118
shares
|
$82,207
0.0% of portfolio
|
Q1 2024
Reduced 26.28%
|
|
Orin Green Financial, LLC
|
May 08, 2024 Q1 2024 |
72,000
shares
|
$77,760
0.04% of portfolio
|
Q1 2024
Reduced 10.0%
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
67,956
shares
|
$73,392
0.0% of portfolio
|
Q1 2024
Reduced 9.05%
|
|
Commonwealth Equity Services, LLC
|
Apr 29, 2024 Q1 2024 |
50,100
shares
|
$54,108
0.0% of portfolio
|
Q3 2023
Reduced 0.2%
|
|
Hsbc Holdings PLC
London, X0 |
May 15, 2024 Q1 2024 |
46,680
shares
|
$50,414
0.0% of portfolio
|
Q1 2024
Added 16.51%
|
|
New York State Common Retirement Fund
|
May 07, 2024 Q1 2024 |
45,655
shares
|
$49,307
0.0% of portfolio
|
Q1 2024
Added 1.23%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
37,788
shares
|
$40,811
0.0% of portfolio
|
Q1 2024
New holding
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2024 Q1 2024 |
33,548
shares
|
$36,231
0.0% of portfolio
|
Q4 2023
New holding
|